| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Judy Savige | Q55692111 |
| Billy G. Hudson | Q60729372 | ||
| P2093 | author name string | Vadim Pedchenko | |
| Shane T Jensen | |||
| James D San Antonio | |||
| J Des Parkin | |||
| P2860 | cites work | Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis | Q21145893 |
| Characterization of a novel type of serine/threonine kinase that specifically phosphorylates the human goodpasture antigen | Q22009444 | ||
| Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth | Q22011031 | ||
| Distinct antitumor properties of a type IV collagen domain derived from basement membrane | Q22253901 | ||
| Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis | Q24290327 | ||
| alpha11beta1 integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal nonmuscle cells | Q24291604 | ||
| Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins | Q24299560 | ||
| A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides | Q24299888 | ||
| A domain-specific usherin/collagen IV interaction may be required for stable integration into the basement membrane superstructure | Q24301986 | ||
| COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps | Q24305076 | ||
| DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation | Q24305439 | ||
| Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB) | Q24317888 | ||
| Osteogenesis imperfecta: translation of mutation to phenotype | Q24515006 | ||
| Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin | Q24533183 | ||
| Characterization of binding properties of the myelin-associated glycoprotein to extracellular matrix constituents | Q24556071 | ||
| Integrin ligands at a glance | Q24600618 | ||
| A sulfilimine bond identified in collagen IV | Q24606334 | ||
| Molecular and mesoscale mechanisms of osteogenesis imperfecta disease in collagen fibrils | Q24642660 | ||
| Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity | Q24652387 | ||
| Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates | Q24656537 | ||
| Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo | Q24669536 | ||
| Matrix metalloproteinases: old dogs with new tricks | Q24795980 | ||
| Structural basis of sequence-specific collagen recognition by SPARC | Q27652906 | ||
| Integrins: bidirectional, allosteric signaling machines | Q27860700 | ||
| Discoidin domain receptor 1 is activated independently of beta(1) integrin | Q28145118 | ||
| A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines | Q28185579 | ||
| Short amino acid sequences derived from C1q receptor (C1q-R) show homology with the alpha chains of fibronectin and vitronectin receptors and collagen type IV | Q28187337 | ||
| Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin | Q28239509 | ||
| Regulation of protease nexin-1 target protease specificity by collagen type IV | Q28243645 | ||
| Binding of nidogen and the laminin-nidogen complex to basement membrane collagen type IV | Q28244654 | ||
| Microfibril-associated glycoprotein-1 (MAGP-1) binds to the pepsin-resistant domain of the alpha3(VI) chain of type VI collagen | Q28247738 | ||
| Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen | Q28253926 | ||
| Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis | Q28257040 | ||
| Mammalian collagen IV | Q28265884 | ||
| Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin | Q28271413 | ||
| Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties | Q28277523 | ||
| The arrangement of intra- and intermolecular disulfide bonds in the carboxyterminal, non-collagenous aggregation and cross-linking domain of basement-membrane type IV collagen | Q28281372 | ||
| Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disorders | Q28282010 | ||
| Binding of mouse and human fibulin-2 to extracellular matrix ligands | Q28285197 | ||
| The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper | Q28289646 | ||
| The complete primary structure of the alpha 2 chain of human type IV collagen and comparison with the alpha 1(IV) chain | Q28292770 | ||
| Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A | Q28301233 | ||
| Role of laminin terminal globular domains in basement membrane assembly | Q28587702 | ||
| Binding of laminin to type IV collagen: a morphological study | Q28645694 | ||
| Interaction of type IV collagen with the isolated integrins alpha 1 beta 1 and alpha 2 beta 1 | Q28647294 | ||
| Reactome knowledgebase of human biological pathways and processes | Q29617596 | ||
| Molecular mapping of the Goodpasture's epitope for glomerulonephritis | Q30439840 | ||
| The alpha 5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency | Q73815597 | ||
| Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility | Q73831601 | ||
| Osteogenesis imperfecta mutations may probe vital functional domains (e.g. proteoglycan binding sites) of type 1 collagen fibrils | Q73989689 | ||
| Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences | Q74495034 | ||
| Non-helical type IV collagen polypeptides in human placenta | Q75235365 | ||
| Conformational studies on the specific cleavage site of Type I collagen (alpha-1) fragment (157-192) by cathepsins K and L by proton NMR spectroscopy | Q77370690 | ||
| The collagenolytic activity of cathepsin K is unique among mammalian proteinases | Q77581104 | ||
| Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1 | Q78127337 | ||
| The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain | Q79758491 | ||
| Sequence dependence of renucleation after a Gly mutation in model collagen peptides | Q80335925 | ||
| Mice lacking the extracellular matrix adaptor protein matrilin-2 develop without obvious abnormalities | Q80421847 | ||
| Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2 | Q80799407 | ||
| Oncothanin, a peptide from the alpha3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis | Q80927165 | ||
| Mechanism of chain selection in the assembly of collagen IV: a prominent role for the alpha2 chain | Q82062563 | ||
| Acetylcholinesterase readthrough peptide shares sequence similarity to the 28-53 peptide sequence of the acetylcholinesterase adhesion-mediating site and competes for ligand binding in vitro | Q94526199 | ||
| Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I domains | Q38296534 | ||
| Different adhesins for type IV collagen on Candida albicans: identification of a lectin-like adhesin recognizing the 7S(IV) domain | Q38299430 | ||
| Structure and biological activity of basement membrane proteins | Q38625595 | ||
| Nm23-H1 promotes adhesion of CAL 27 cells in vitro | Q39876921 | ||
| Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor | Q39942587 | ||
| Bovine prolactin-related protein-I is anchored to the extracellular matrix through interactions with type IV collagen | Q40016190 | ||
| Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor. | Q40163119 | ||
| Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3. | Q40274571 | ||
| Specific recognition of the collagen triple helix by chaperone HSP47. II. The HSP47-binding structural motif in collagens and related proteins | Q40315228 | ||
| Integrin activation state determines selectivity for novel recognition sites in fibrillar collagens | Q40519430 | ||
| Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis | Q40680465 | ||
| The alpha 1 beta 1 integrin recognition site of the basement membrane collagen molecule [alpha 1(IV)]2 alpha 2(IV). | Q40875207 | ||
| Anti-angiogenic cues from vascular basement membrane collagen | Q40879854 | ||
| The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain. | Q40962039 | ||
| Goodpasture syndrome. Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3(IV) chain of basement membrane collagen | Q41135760 | ||
| Interaction of enteropathogenic Yersinia enterocolitica with complex basement membranes and the extracellular matrix proteins collagen type IV, laminin-1 and -2, and nidogen/entactin | Q41497313 | ||
| Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration | Q41546361 | ||
| Characterization of a type IV collagen major cell binding site with affinity to the alpha 1 beta 1 and the alpha 2 beta 1 integrins | Q41683198 | ||
| Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: implications for development | Q41696868 | ||
| New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. | Q41724444 | ||
| Biochemical alterations in collagen IV induced by in vitro glycation | Q41782428 | ||
| Comparative analysis of the noncollagenous NC1 domain of type IV collagen: identification of structural features important for assembly, function, and pathogenesis | Q41854234 | ||
| Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion | Q41896828 | ||
| Binding of human plasminogen to basement-membrane (type IV) collagen | Q42203962 | ||
| Binding of lymphoid chemokines to collagen IV that accumulates in the basal lamina of high endothelial venules: its implications in lymphocyte trafficking | Q42518984 | ||
| A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization | Q42613103 | ||
| Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria | Q42752920 | ||
| Nonenzymatic glycation of type I collagen. The effects of aging on preferential glycation sites | Q43559656 | ||
| The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B. | Q44037422 | ||
| Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling | Q44053821 | ||
| Alport syndrome mutations in type IV tropocollagen alter molecular structure and nanomechanical properties | Q44448354 | ||
| Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion | Q44650500 | ||
| Identification of S-hydroxylysyl-methionine as the covalent cross-link of the noncollagenous (NC1) hexamer of the alpha1alpha1alpha2 collagen IV network: a role for the post-translational modification of lysine 211 to hydroxylysine 211 in hexamer as | Q46542176 | ||
| Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy | Q46722530 | ||
| Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin. | Q46804676 | ||
| Type IV collagens regulate BMP signalling in Drosophila | Q47070333 | ||
| The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens | Q48564306 | ||
| Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence | Q48566472 | ||
| Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet Glycoprotein VI contains two glycine-proline-hydroxyproline triplets. | Q48697081 | ||
| Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. | Q50447866 | ||
| X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. | Q50496896 | ||
| Molecular modeling of protein-glycosaminoglycan interactions. | Q52546742 | ||
| Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. | Q52564340 | ||
| Interstitial collagens I, III, and VI sequester and modulate the multifunctional cytokine oncostatin M. | Q52960794 | ||
| Localization of binding sites for laminin, heparan sulfate proteoglycan and fibronectin on basement membrane (type IV) collagen. | Q54146035 | ||
| Type IV collagen α6 chain-derived noncollagenous domain 1 (α6(IV)NC1) inhibits angiogenesis and tumor growth | Q58214810 | ||
| COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke | Q59697997 | ||
| Heparin type IV collagen interactions: equilibrium binding and inhibition of type IV collagen self-assembly | Q67980838 | ||
| Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV | Q68506540 | ||
| Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation. Implications for diabetes mellitus | Q68983713 | ||
| The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein | Q69371796 | ||
| Binding domain for laminin on type IV collagen | Q69942003 | ||
| Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV | Q70168568 | ||
| Studies on human laminin and laminin-collagen complexes | Q70212561 | ||
| Compressed microfibril models of the native collagen fibril | Q71275394 | ||
| A peptide model of basement membrane collagen alpha 1 (IV) 531-543 binds the alpha 3 beta 1 integrin | Q71573426 | ||
| The alpha 3 chain of type IV collagen prevents activation of human polymorphonuclear leukocytes | Q72724307 | ||
| Human keratinocyte migration on type IV collagen. Roles of heparin-binding site and alpha 2 beta 1 integrin | Q72736007 | ||
| Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells | Q73010293 | ||
| Effect of HSP47 on prolyl 4-hydroxylation of collagen model peptides | Q73109631 | ||
| Human factor IX binds to specific sites on the collagenous domain of collagen IV | Q73456220 | ||
| Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies | Q73524039 | ||
| A cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells | Q73575354 | ||
| Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library | Q30656278 | ||
| Melanoma cell CD44 interaction with the alpha 1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation | Q30885646 | ||
| Multiple binding sites in collagen type I for the integrins alpha1beta1 and alpha2beta1. | Q30924957 | ||
| Crucial role of the CB3-region of collagen IV in PARF-induced acute rheumatic fever | Q33413755 | ||
| Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. | Q34088135 | ||
| Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis | Q34088479 | ||
| Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen | Q34101398 | ||
| Tumstatin, an endothelial cell-specific inhibitor of protein synthesis | Q34107979 | ||
| Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds | Q34131204 | ||
| alpha 11beta 1 integrin recognizes the GFOGER sequence in interstitial collagens | Q34166441 | ||
| The role of collagen-derived proteolytic fragments in angiogenesis | Q34375953 | ||
| Collagens, modifying enzymes and their mutations in humans, flies and worms | Q34544297 | ||
| Mammalian collagen receptors | Q34586505 | ||
| The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix | Q34748818 | ||
| Collagen polymorphism: Its origins in the amino acid sequence | Q35110984 | ||
| Alport's syndrome, Goodpasture's syndrome, and type IV collagen. | Q35157829 | ||
| Synthetic heterotrimeric collagen peptides as mimics of cell adhesion sites of the basement membrane. | Q35680922 | ||
| The collagen receptor subfamily of the integrins | Q35775496 | ||
| Procollagen trafficking, processing and fibrillogenesis. | Q36078993 | ||
| Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy | Q36216111 | ||
| Basement membrane structure in situ: evidence for lateral associations in the type IV collagen network. | Q36217206 | ||
| Identification of a multifunctional, cell-binding peptide sequence from the a1(NC1) of type IV collagen | Q36223629 | ||
| Novel roles for alpha3beta1 integrin as a regulator of cytoskeletal assembly and as a trans-dominant inhibitor of integrin receptor function in mouse keratinocytes | Q36290617 | ||
| The binding of heparin to type IV collagen: domain specificity with identification of peptide sequences from the alpha 1(IV) and alpha 2(IV) which preferentially bind heparin. | Q36417079 | ||
| Interaction of Dr adhesin with collagen type IV is a critical step in Escherichia coli renal persistence | Q36446772 | ||
| Molecular recognition in the assembly of collagens: terminal noncollagenous domains are key recognition modules in the formation of triple helical protomers. | Q36643333 | ||
| Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network | Q36666850 | ||
| Is SPARC an evolutionarily conserved collagen chaperone? | Q36769633 | ||
| Type IV collagen-derived angiogenesis inhibitors | Q36865710 | ||
| The major pilin subunit of the AAF/II fimbriae from enteroaggregative Escherichia coli mediates binding to extracellular matrix proteins | Q36898489 | ||
| Acetylcholinesterase in cell adhesion, neurite growth and network formation | Q37060536 | ||
| Goodpasture antigen-binding protein is a soluble exportable protein that interacts with type IV collagen. Identification of novel membrane-bound isoforms | Q37142570 | ||
| Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression | Q37190487 | ||
| Identification of the endothelial cell binding site for factor IX. | Q37309632 | ||
| P433 | issue | 2 | |
| P921 | main subject | ligand binding | Q61659151 |
| P304 | page(s) | 127-143 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Human Mutation | Q5937269 |
| P1476 | title | Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes | |
| P478 | volume | 32 |
| Q53229806 | A mutation in COL4A2 causes autosomal dominant porencephaly with cataracts. |
| Q89836570 | Adverse effects of Alport syndrome-related Gly missense mutations on collagen type IV: Insights from molecular simulations and experiments |
| Q38221023 | Age-related macular degeneration and changes in the extracellular matrix |
| Q37619281 | Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations. |
| Q38238367 | Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment |
| Q37475103 | Biological role of prolyl 3-hydroxylation in type IV collagen |
| Q47898371 | Building collagen IV smart scaffolds on the outside of cells. |
| Q39722461 | CD and NMR investigation of collagen peptides mimicking a pathological Gly-Ser mutation and a natural interruption in a similar highly charged sequence context |
| Q91732551 | COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity |
| Q38036904 | COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets |
| Q91725232 | COL4A2 in the tissue-specific extracellular matrix plays important role on osteogenic differentiation of periodontal ligament stem cells |
| Q35671528 | COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke |
| Q33574848 | Collagen IV and basement membrane at the evolutionary dawn of metazoan tissues |
| Q38682069 | Comprehensive Characterization of Glycosylation and Hydroxylation of Basement Membrane Collagen IV by High-Resolution Mass Spectrometry. |
| Q38110459 | DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome |
| Q24604831 | Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling |
| Q38313644 | Engineering multiple biological functional motifs into a blank collagen-like protein template from Streptococcus pyogenes |
| Q38311017 | Evidence for activation of the unfolded protein response in collagen IV nephropathies |
| Q57176794 | Expert consensus guidelines for the genetic diagnosis of Alport syndrome |
| Q36929945 | Extracellular chloride signals collagen IV network assembly during basement membrane formation |
| Q37398464 | FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney |
| Q40556586 | Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury |
| Q90182401 | Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen |
| Q33985350 | Glycosylation modulates melanoma cell α2β1 and α3β1 integrin interactions with type IV collagen |
| Q36037202 | High levels of the extracellular matrix proteoglycan decorin are associated with inhibition of testicular function |
| Q38005762 | Human pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host |
| Q33728344 | Influence of ranibizumab treatment on the extracellular matrix in patients with neovascular age-related macular degeneration. |
| Q36981267 | Local amino acid sequence patterns dominate the heterogeneous phenotype for the collagen connective tissue disease Osteogenesis Imperfecta resulting from Gly mutations |
| Q92357066 | Modification of an aggressive model of Alport Syndrome reveals early differences in disease pathogenesis due to genetic background |
| Q60106617 | Modular approach for resolving and mapping complex neural and other cellular structures and their associated deformation fields in three dimensions |
| Q54243645 | Mutation spectrum and differential gene expression in cystic and solid vestibular schwannoma. |
| Q28080691 | Ocular features in Alport syndrome: pathogenesis and clinical significance |
| Q36593214 | Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain? |
| Q52729803 | Post-translational modification of type IV collagen with 3-hydroxyproline affects its interactions with glycoprotein VI and nidogens 1 and 2. |
| Q64056675 | Quantified forces between HepG2 hepatocarcinoma and WA07 pluripotent stem cells with natural biomaterials correlate with in vitro cell behavior |
| Q37101426 | Temporal macular thinning associated with X-linked Alport syndrome. |
| Q41006430 | The collαgen III fibril has a "flexi-rod" structure of flexible sequences interspersed with rigid bioactive domains including two with hemostatic roles |
| Q52720562 | The triple helix of collagens - an ancient protein structure that enabled animal multicellularity and tissue evolution. |
| Q47365590 | Towards a defined ECM and small molecule based monolayer culture system for the expansion of mouse and human intestinal stem cells |
| Q36132825 | X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations |
| Q37709334 | siRNA-mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration |
| Q92459922 | α-Integrins dictate distinct modes of type IV collagen recruitment to basement membranes |
Search more.